Cross Country Healthcare (CCRN) EPS (Weighted Average and Diluted) (2016 - 2025)
Cross Country Healthcare (CCRN) has disclosed EPS (Weighted Average and Diluted) for 16 consecutive years, with -$0.15 as the latest value for Q3 2025.
- For the quarter ending Q3 2025, EPS (Weighted Average and Diluted) fell 287.5% year-over-year to -$0.15, compared with a TTM value of -$0.49 through Sep 2025, down 1533.33%, and an annual FY2024 reading of -$0.44, down 121.46% over the prior year.
- EPS (Weighted Average and Diluted) was -$0.15 for Q3 2025 at Cross Country Healthcare, up from -$0.2 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at $2.07 in Q4 2021 and bottomed at -$0.47 in Q2 2024.
- Average EPS (Weighted Average and Diluted) over 5 years is $0.52, with a median of $0.36 recorded in 2023.
- The sharpest move saw EPS (Weighted Average and Diluted) soared 1650.0% in 2021, then crashed 287.5% in 2025.
- Year by year, EPS (Weighted Average and Diluted) stood at $2.07 in 2021, then tumbled by 49.28% to $1.05 in 2022, then plummeted by 73.33% to $0.28 in 2023, then crashed by 142.86% to -$0.12 in 2024, then fell by 25.0% to -$0.15 in 2025.
- Business Quant data shows EPS (Weighted Average and Diluted) for CCRN at -$0.15 in Q3 2025, -$0.2 in Q2 2025, and -$0.02 in Q1 2025.